OBJECTIVES: Osteocalcin is a protein secreted by osteoblasts with a versatile endocrine role. Several domains in which it plays a role-stress response, monoamine synthesis, and cognitive functioning-are implicated also in the pathophysiology of major depressive disorder. In search of possible objective biomarkers of depression, the aim of the study was to assess the relationship between osteocalcin and depressive symptoms during the treatment of depressive episode. METHODS: The study included female inpatients with at least moderate depressive episode. In these patients, depression severity was measured using the Montgomery-Åsberg Depression Rating Scale (MADRS), and osteocalcin levels were assessed before the stabilization of antidepressive treatment and after 6 weeks. Relationships between osteocalcin levels and symptoms were analyzed with mixed-effect and linear models, taking into account age, menopausal status, and body mass index. RESULTS: In 11 out of 13 enrolled inpatients, osteocalcin levels decreased during the first 6 weeks of treatment; this decrease was significant according to the mixed-effects model (t = -2.345, p = 0.019). According to the linear model, this decrease was significantly associated with reduction in depressive symptom severity (t = 2.673, p = 0.028). Osteocalcin was not associated with initial depressive symptom severity, and initial osteocalcin levels did not predict response to treatment. Limitations of the study include low sample size and inclusion of both pre- and postmenopausal women of various ages. CONCLUSIONS: This preliminary study suggests that osteocalcin may be a candidate biomarker of antidepressive treatment response and that this topic warrants further investigation.

Department of Biochemistry Faculty of Medicine Masaryk University Brno Czechia

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czechia

Department of Psychiatry Faculty of Medicine University Hospital Brno Masaryk University Brno Czechia

RECETOX Faculty of Science Masaryk University Brno Czechia

Zobrazit více v PubMed

Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. (2013) 155:228–41. 10.1016/j.cell.2013.08.042 PubMed DOI PMC

O'Connor EM, Durack E. Osteocalcin: the extra-skeletal role of a vitamin K-dependent protein in glucose metabolism. J Nutr Intermediary Metabol. (2017) 7:8–13. 10.1016/j.jnim.2017.01.001 DOI

Gundberg CM, Looker AC, Nieman SD, Calvo MS. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone. (2002) 31:703–8. 10.1016/S8756-3282(02)00902-X PubMed DOI

Hannemann A, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, et al. Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania. BMC Endocr Disord. (2013) 13:11. 10.1186/1472-6823-13-11 PubMed DOI PMC

Ahn N, Kim K. Effects of 12-week exercise training on osteocalcin, high-sensitivity C-reactive protein concentrations, and insulin resistance in elderly females with osteoporosis. J Phys Therapy Sci. (2016) 28:2227–31. 10.1589/jpts.28.2227 PubMed DOI PMC

Kim YS, Nam JS, Yeo DW, Kim KR, Suh SH, Ahn CW. The effects of aerobic exercise training on serum osteocalcin, adipocytokines and insulin resistance on obese young males. Clin Endocrinol. (2015) 82:686–94. 10.1111/cen.12601 PubMed DOI

Singh S. Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women. J Clin DiagnRes. (2015) 9:RC04-7. 10.7860/JCDR/2015/14857.6318 PubMed DOI PMC

Liu Z, Chen R, Jiang Y, Yang Y, He L, Luo C, et al. A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls. BMC Musculoskeletal Disord. (2019) 20:532. 10.1186/s12891-019-2863-y PubMed DOI PMC

Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone. (2016) 82:42–49. 10.1016/j.bone.2015.05.046 PubMed DOI PMC

Liu X, Liu Y, Mathers J, Cameron M, Levinger I, Yeap BB, et al. Osteocalcin and measures of adiposity: a systematic review and meta-analysis of observational studies. Arch Osteoporos. (2020) 15:145. 10.1007/s11657-020-00812-6 PubMed DOI

Moon JS, Jin MH, Koh HM. Association between serum osteocalcin levels and metabolic syndrome according to the menopausal status of Korean women. J Korean Med Sci. (2021) 36:e56. 10.3346/jkms.2021.36.e56 PubMed DOI PMC

Berger JM, Singh P, Khrimian L, Morgan DA, Chowdhury S, Arteaga-Solis E, et al. Mediation of the acute stress response by the skeleton. Cell Metab. (2019) 30:890–902.e8. 10.1016/j.cmet.2019.08.012 PubMed DOI PMC

Shan C, Ghosh A, Guo Xz, Wang Sm, Hou Yf, Li St, et al. Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders. Mol Brain. (2019) 12:23. 10.1186/s13041-019-0444-5 PubMed DOI PMC

Ferrari F, Villa RF. The neurobiology of depression: an integrated overview from biological theories to clinical evidence. Mol Neurobiol. (2017) 54:4847–65. 10.1007/s12035-016-0032-y PubMed DOI

Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, et al. Bone mineral density in women with depression. N Engl J Med. (1996) 335:1176–81. 10.1056/NEJM199610173351602 PubMed DOI

Altindag O, Altindag A, Asoglu M, Gunes M, Soran N, Deveci Z. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract. (2007) 61:416–20. 10.1111/j.1742-1241.2006.01276.x PubMed DOI

Skowrońska-Jówiak E, Gałecki P, Głowacka E, Wojtyła C, Biliński P, Lewiński A. Bone metabolism in patients treated for depression. Int J Environ Res Public Health. (2020) 17:17134756. 10.3390/ijerph17134756 PubMed DOI PMC

Herrán A, Amado JA, García-Unzueta MT, Vázquez-Barquero JL, Perera L, González-Macías J. Increased bone remodeling in first-episode major depressive disorder. Psychosom Med. (2000) 62:779–82. 10.1097/00006842-200011000-00006 PubMed DOI

Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am J Psychiatry. (2005) 162:168–74. 10.1176/appi.ajp.162.1.168 PubMed DOI

Cizza G, Mistry S, Nguyen VT, Eskandari F, Martinez P, Torvik S, et al. Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study. PLoS One. (2012) 7:e40894. 10.1371/journal.pone.0040894 PubMed DOI PMC

Nguyen MM, Anita NZ, Darwish L, Major-Orfao C, Colby-Milley J, Wong SK, et al. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes. Psychoneuroendocrinology. (2020) 122:104878. 10.1016/j.psyneuen.2020.104878 PubMed DOI

Aydin H, Mutlu N, Akbas NBG. Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women. J Psychiatr Res. (2011) 45:1316–1320. 10.1016/j.jpsychires.2011.04.005 PubMed DOI

Association AP editor. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; (2013).

Montgomery SA, Åsberg M. a new depression scale designed to be sensitive to change. Br J Psychiatry. (1979) 134:382–9. 10.1192/bjp.134.4.382 PubMed DOI

Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: validation of the massachusetts general hospital antidepressant treatment history questionnaire (ATRQ). CNS Neurosci Therapeut. (2010) 16:322–5. 10.1111/j.1755-5949.2009.00102.x PubMed DOI PMC

Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, et al. Second generation antipsychotics in the treatment of major depressive disorder: an update. Chonnam Med J. (2016) 52:159. 10.4068/cmj.2016.52.3.159 PubMed DOI PMC

Cohen J. A power primer. Psychol Bull. (1992) 112:155–9. 10.1037/0033-2909.112.1.155 PubMed DOI

R Core Team . R: A Language and Environment for Statistical Computing. Vienna: R Core Team; (2021).

Janik M, Stuss M, Michalska-Kasiczak M, Jegier A, Sewerynek E. Effects of physical activity on sclerostin concentrations. Endokrynol Pol. (2018) 69:142–9. 10.5603/EP.a2018.0008 PubMed DOI

Hori H, Koga N, Hidese S, Nagashima A, Kim Y, Higuchi T, et al. 24-h activity rhythm and sleep in depressed outpatients. J Psychiatr Res. (2016) 77:27–34. 10.1016/j.jpsychires.2016.02.022 PubMed DOI

Falkenbach A, Sedlmeyer A, Herold M. Decreased serum concentration of osteocalcin after sunshine exposure. In: Holick MF, Jung EG, editors. Biologic Effects of Light 1998: Proceedings of a Symposium Basel, Switzerland November 1–3. 1998. Boston, MA: Springer US; (1999). p. 67–70.

Ortuño MJ, Robinson ST, Subramanyam P, Paone R, Huang Yy, Guo XE, et al. Serotonin reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local antiresorptive effect. Nat Med. (2016) 22:1170–9. 10.1038/nm.4166 PubMed DOI PMC

Zhang B, Deng L, Wu H, Lu X, Peng L, Wu R, et al. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps. Schizophr Res. (2016) 176:259–63. 10.1016/j.schres.2016.06.034 PubMed DOI

Camerino C, Conte E, Cannone M, Caloiero R, Fonzino A, Tricarico D. Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mRNA quantitative evaluation and linear correlation analysis. Front Physiol. (2016) 7:456. 10.3389/fphys.2016.00456 PubMed DOI PMC

Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X, et al. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One. (2017) 12:e0172270. 10.1371/journal.pone.0172270 PubMed DOI PMC

Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder–translating findings from humans to animal models and back. Front Psychiatry. (2020) 10:974. 10.3389/fpsyt.2019.00974 PubMed DOI PMC

Facial emotion processing in patients with borderline personality disorder as compared with healthy controls: an fMRI and ECG study